02/12/2025 7:30 AM | Prosight Management, LP (Filed by) Vincerx Pharma (Subject)
| Form SCHEDULE 13G/A | |
02/11/2025 6:09 PM | Long Focus Capital Management, LLC (Filed by) Vincerx Pharma (Subject)
| Form SCHEDULE 13G/A | |
02/06/2025 3:05 PM | Vincerx Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/06/2025 3:06 PM | Vincerx Pharma (Filer)
| Form DEFA14A | |
01/29/2025 3:05 PM | Vincerx Pharma (Filer)
| Form DEFA14A | |
01/23/2025 3:10 PM | Vincerx Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/23/2025 3:13 PM | Vincerx Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/23/2025 3:15 PM | Vincerx Pharma (Filer)
| Form DEFA14A | |
01/21/2025 3:31 PM | Vincerx Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/21/2025 3:29 PM | Vincerx Pharma (Filer)
| Form 424B5 | |
01/16/2025 4:11 PM | Vincerx Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for VINC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Vincerx Pharma and its competitors with MarketBeat's FREE daily newsletter.
|
12/27/2024 3:12 PM | Vincerx Pharma (Filer)
| Form 424B5 | |
12/27/2024 3:13 PM | Vincerx Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/25/2024 4:05 PM | Vincerx Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/14/2024 10:57 AM | BANK OF AMERICA CORP /DE/ (Filed by) Vincerx Pharma (Subject)
| Form SC 13G/A | |
11/13/2024 7:32 AM | Prosight Management, LP (Filed by) Vincerx Pharma (Subject)
| Form SC 13G/A | |
11/05/2024 8:15 AM | Vincerx Pharma (Filer)
| Form PRE 14A | |
09/30/2024 5:57 AM | Vincerx Pharma (Subject)
| Form SC TO-I/A | |
09/10/2024 3:02 PM | Vincerx Pharma (Subject)
| Form SC TO-I/A | |
08/16/2024 3:01 PM | Vincerx Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/14/2024 7:11 PM | THOMAS TOM C (Reporting) Vincerx Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2024 7:00 PM | Izumi Raquel E. (Reporting) Vincerx Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2024 7:03 PM | Seelenberger Alexander A. (Reporting) Vincerx Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2024 7:07 PM | Hamdy Ahmed MD (Reporting) Vincerx Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/08/2024 3:37 PM | Vincerx Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/08/2024 3:39 PM | Vincerx Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/08/2024 3:45 PM | Vincerx Pharma (Filer)
| Form DEF 14A | |
05/29/2024 7:54 PM | Hamdy Ahmed MD (Reporting) Vincerx Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 7:55 PM | THOMAS TOM C (Reporting) Vincerx Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 8:03 PM | Izumi Raquel E. (Reporting) Vincerx Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 8:12 PM | Seelenberger Alexander A. (Reporting) Vincerx Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/28/2024 3:35 PM | Bushnell Laura I. (Reporting) Vincerx Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/28/2024 3:36 PM | Stevens Ruth E. (Reporting) Vincerx Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/28/2024 3:36 PM | Lee John H. (Reporting) Vincerx Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/28/2024 3:38 PM | Salva Francisco D. (Reporting) Vincerx Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/28/2024 3:40 PM | Druker Brian (Reporting) Vincerx Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/28/2024 3:06 PM | Vincerx Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/14/2024 3:21 PM | Vincerx Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/03/2024 8:00 AM | Prosight Management, LP (Filed by) Vincerx Pharma (Subject)
| Form SC 13G | |
04/29/2024 4:14 PM | Vincerx Pharma (Filer)
| Form 424B5 | |
04/10/2024 3:03 PM | Vincerx Pharma (Filer)
| Form DEFA14A | |
Ex-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000” (Ad) Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000.
Should you sit on the sideline while this is happening? That's why we put together a 100% FREE 2025 Gold Guide to show you exactly how to protect and grow y |
04/10/2024 3:09 PM | Vincerx Pharma (Filer)
| Form ARS | |
04/09/2024 4:09 PM | GOLDMAN SACHS GROUP INC (Filed by) GOLDMAN SACHS GROUP INC (Filed by) Vincerx Pharma (Subject)
| Form SC 13G/A | |
04/08/2024 3:35 PM | Vincerx Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/29/2024 3:12 PM | Vincerx Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/29/2024 2:14 PM | Vincerx Pharma (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/29/2024 2:26 PM | Vincerx Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/08/2024 6:58 PM | THOMAS TOM C (Reporting) Vincerx Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 7:00 PM | Hamdy Ahmed MD (Reporting) Vincerx Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 7:04 PM | Seelenberger Alexander A. (Reporting) Vincerx Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 7:08 PM | Izumi Raquel E. (Reporting) Vincerx Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |